Sentara Infusion Services recalls METHADONE (a) 2.5MG IN 5ML NS SYRINGE, (b) 4MG IN 5ML NS SYRINGE, pain, Rx Only, Sentara Home Infusion Pharmacy Service
Recalled February 22, 2023 · FDA recall D-0304-2023 · Sentara Infusion Services
Hazard
Lack of sterility assurance · FDA Class II
Units
19 syringes
Sold at
Dispensed to Patients Nationwide.
Description
Lack of sterility assurance
Product
METHADONE (a) 2.5MG IN 5ML NS SYRINGE, (b) 4MG IN 5ML NS SYRINGE, pain, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320
Manufacturer(s)
Sentara Infusion Services
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →